학술논문
Nontargeted and Targeted Metabolomic Profiling Reveals Novel Metabolite Biomarkers of Incident Diabetes in African Americans
Document Type
article
Author
Chen, Zsu-Zsu; Pacheco, Julian Avila; Gao, Yan; Deng, Shuliang; Peterson, Bennet; Shi, Xu; Zheng, Shuning; Tahir, Usman A; Katz, Daniel H; Cruz, Daniel E; Ngo, Debby; Benson, Mark D; Robbins, Jeremy M; Guo, Xiuqing; del Rocio Sevilla Gonzalez, Magdalena; Manning, Alisa; Correa, Adolfo; Meigs, James B; Taylor, Kent D; Rich, Stephen S; Goodarzi, Mark O; Rotter, Jerome I; Wilson, James G; Clish, Clary B; Gerszten, Robert E
Source
Diabetes. 71(11)
Subject
Language
Abstract
Nontargeted metabolomics methods have increased potential to identify new disease biomarkers, but assessments of the additive information provided in large human cohorts by these less biased techniques are limited. To diversify our knowledge of diabetes-associated metabolites, we leveraged a method that measures 305 targeted or "known" and 2,342 nontargeted or "unknown" compounds in fasting plasma samples from 2,750 participants (315 incident cases) in the Jackson Heart Study (JHS)-a community cohort of self-identified African Americans-who are underrepresented in omics studies. We found 307 unique compounds (82 known) associated with diabetes after adjusting for age and sex at a false discovery rate of